Source: PR Newswire

Press Release: Bistro MD : Sustainable Weight Loss with GLP-1's and bistroMD

/PRNewswire/ -- Glucagon-Like Peptide-1 (GLP-1's) are medications that manage blood sugar levels for people with type-2 diabetes. Ozempic, a type of GLP-1, has...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Edward Cederquist's photo - Co-Founder & CEO of bistroMD

Co-Founder & CEO

Edward Cederquist

CEO Approval Rating

88/100

Read more